Register entry
- Registered sites
- 0
- Active NDC listings
- 3
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
33 active NDC listings: 3 human prescription drug. By marketing category: BLA 3.
| Dosage form | NDCs |
|---|---|
| patch | 3 |
| Route | NDCs |
|---|---|
| topical | 3 |
| Labeller name on the listing | NDCs |
|---|---|
| corza medical gmbh | 3 |
Catalogue
Marketed products
3| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| TachoSil | THROMBIN HUMAN and FIBRINOGEN | patch, topical | 83078-701BLA |
| TachoSil | THROMBIN HUMAN and FIBRINOGEN | patch, topical | 83078-702BLA |
| TachoSil | THROMBIN HUMAN and FIBRINOGEN | patch, topical | 83078-704BLA |
Enquiry
Common questions
- Is Corza Medical GmbH FDA approved?
- Corza Medical GmbH holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Corza Medical GmbH make?
- 3 products are listed under Corza Medical GmbH in the openFDA NDC Directory, most often as patch. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.